Sensors are changing our lives, also in healthcare (for the better). During the opening ceremony of the Healthcare and Social ICT R+D+I Conference held in the University of Vic on 28 September, Marina Geli, coordinator of the Healthcare and Social Studies Centre (CESS), highlighted that sensor technology is essential to advance patient empowerment in the home.
Descubre las últimas noticias de Devicare
This week Vienna is hosting the largest European Urolithiasis Meeting, organised every two years by the European Association of Urology (EAU). The event will bring together opinion leaders and experts who will present the latest international scientific advances to improve the treatment of this disease.
Devicare has revamped the websites for their two medical solutions that are unique on the market (first-in-class): Tao-Control® for chronic anticoagulated patients and the Lit-Control® product line for urinary health.
The Catalan Finance Institute (ICF), in collaboration with ACCIÓ (Agency for business competitiveness of the Generalitat of Catalonia), granted Devicare participation loan of 133,000 euros as part of the Corporate Entrepreneurship Programme in order to join...
The Association of Out-Patient Clinics and Entities of the Community of Madrid (ACESIMA) and Devicare have signed a strategic collaboration agreement to promote R&D&I and the use and training of innovative healthcare services and technologies intended for the in-home self-management of chronic patients in therapeutic fields such as the cardiovascular and urological fields, among others.
UIB, the Hospital de Manacor and Devicare launch a study to evaluate the effect of theobromine, the first inhibitor that prevents renal lithiasis
The Laboratory of Renal Lithiasis Research at the University of the Balearic Islands (UIB) will carry out a study among patients to evaluate the effects of theobromine, a substance that acts as an inhibitor of uric acid crystallisation in urine and that was patented as a dietary supplement by the UIB research team led by Dr. Fèlix Grases. The study will be carried out in collaboration with the Urology Service of the Hospital de Manacor,...
Devicare has joined the Associate Collaborators' Forum (FAC) of The Catalan Hospitals Union (La Unió), a body made up of more than 25 industrial and service companies that operate in the health, social and attention to dependency fields. Through this forum, La Unió aims to promote the relationship between the associate collaborators, such as Devicare, and the health and social centers of Catalonia in order to encourage partnerships for innovation in management and also strengthen the role of business lobbying in the sector.
Devicare has signed an agreement with the company Inmave to market the family of Lit-Control® products in Colombia for the domiciliary control of frequent urological pathologies. Colombia is the second American country and the fourth globally, after Spain, Mexico and France, to distribute this first-in-class method. The two companies have begun the regulation process with the Colombian National Institute for Medicine and Food Surveillance (INVIMA) with the support of ACCIÓ de Bogotá's office.
Devicare has signed a collaboration agreement with the Allegra Residential Complex in Sabadell, Barcelona in order to offer Lit-Control® and Tao-Control® to its residents. These two innovative services will allow users of the nursing home (161 beds), rental apartments (27 beds) and the day centre who suffer from long-term urological diseases, such as recurrent urinary tract infections, or who take oral anticoagulants, to self-monitor their health with the benefits that this entails.
Devicare se prepara para introducir en Francia la familia de productos Lit-Control® (dispositivo médico y suplementos alimenticios) y así potenciar el autocontrol domiciliario de patologías urológicas frecuentes a través del manejo y el control del pH urinario. Con este fin, la compañía acaba de incorporar al Dr. François Schutze como Country Manager. El Dr. François…